COVID Town Hall - Part 2

Part II – Audience Questions 33:32 What about the timing of hydroxychloroquine use and for how long? 34:50 Should patients on bDMARDs or tsDMARDs (because of presumed risk) not go to work and should we write letters for such people? 37:05 Bush Administration disaster preparedness guidelines and supporting patients 39:06 What infusions should we not do? Denosumab? Zolendronic acid? 41:09 What to do about tocilizumab infusions being COVID diverted? What are the alternatives? 44:09 Should you start your lupus or RA patient on hydroxychloroquine or a new biologic in this era? 46:58 A patient has a resolved COVID-19 infection, would you start a biologic if needed? 47:21 Is anyone worried about the cardiotoxicity of hydroxychloroquine or chloroquine? 48:42 Would you the doctor, self-medicate, or prophylax, with HCQ if you have new onset suspicious symptoms? 50:04 Should rheumatologists do inpatient consults during the COVID? 51:30 If tests were universally available, would you test all your rheumatology patients for COVID-19?